Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03272477 |
|---|---|
| Brief Title: | Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment Under Adjuvant Therapy in Operable HER2+/HR+ Breast Cancer Patients (TP-II) |
| First Submitted : | August 10, 2017 |
| First Submitted that Met QC Criteria : | September 1, 2017 |
| First Posted : | September 5, 2017 |
| Last Update Submitted that Met QC Criteria : | April 16, 2024 |
| Last Update Posted : | April 17, 2024 |